Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Registered Cohort Study on Cerebellar Ataxia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04010214
Recruitment Status : Recruiting
First Posted : July 8, 2019
Last Update Posted : November 13, 2020
Sponsor:
Information provided by (Responsible Party):
Ning Wang, MD., PhD., First Affiliated Hospital of Fujian Medical University

Brief Summary:
Cerebellar ataxia is a form of ataxia originating in the cerebellum. Cerebellar ataxia can occur as a result of many diseases and may present with symptoms of an inability to coordinate balance, gait, extremity and eye movements. To understand the clinical and genetic characteristics of cerebellar ataxia, we establish a registered cohort to follow up Chinese patients with cerebellar ataxia.

Condition or disease Intervention/treatment
Cerebellar Ataxia Other: No intervention

Layout table for study information
Study Type : Observational
Estimated Enrollment : 1500 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: A Registered Cohort Study on Cerebellar Ataxia
Actual Study Start Date : July 1, 2019
Estimated Primary Completion Date : December 2039
Estimated Study Completion Date : December 2059



Intervention Details:
  • Other: No intervention
    No intervention


Primary Outcome Measures :
  1. The incidence of hereditary cerebellar ataxia [ Time Frame: Up to 20years ]
    Look for the causative gene in the patient with cerebellar ataxia



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Patients with cerebellar ataxia who are diagnosed in the First Affiliated Hospital of Fujian Medical University by tow neurologists.
Criteria

Inclusion Criteria:

  • Patients with cerebellar ataxia based on the diagnoses of tow neurologists
  • Relatives of patients with cerebellar ataxia
  • Unrelated healthy controls
  • Participants or legal guardian(s) willing and able to complete the informed consent process

Exclusion Criteria:

  • Participants are unable to comply with trial procedures and visit schedule

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04010214


Contacts
Layout table for location contacts
Contact: Shi-Rui Gan, MD.Phd +8613850172725 ganshirui@fjmu.edu.cn
Contact: Yi Lin, MD.Phd +8613615039153 linyi7811@163.com

Locations
Layout table for location information
China, Fujian
Department of Neurology ,First Affiliated Hospital Fujian Medical University Recruiting
Fuzhou, Fujian, China, 350005
Sponsors and Collaborators
Ning Wang, MD., PhD.
Layout table for additonal information
Responsible Party: Ning Wang, MD., PhD., The Vice President, First Affiliated Hospital of Fujian Medical University
ClinicalTrials.gov Identifier: NCT04010214    
Other Study ID Numbers: MRCTA,ECFAH of FMU[2019]195
First Posted: July 8, 2019    Key Record Dates
Last Update Posted: November 13, 2020
Last Verified: November 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Ataxia
Cerebellar Ataxia
Dyskinesias
Neurologic Manifestations
Nervous System Diseases
Cerebellar Diseases
Brain Diseases
Central Nervous System Diseases